Testosterone Cypionate Cost in Wyoming 2026

Prescription access and medication affordability image for Testosterone Cypionate Cost in Wyoming 2026

At a glance

  • Cash-pay retail price / ~$60/month at Wyoming pharmacies in 2026
  • Manufacturer list price / ~$100/month for branded or generic vials
  • Compounded 503A price / ~$80/month from licensed Wyoming compounders
  • Wyoming Medicaid coverage / Not covered for male hypogonadism
  • Telehealth prescribing / Permitted under Wyoming law
  • Typical dose / 100 to 200 mg intramuscular or subcutaneous, once or twice weekly
  • Prescription required / Yes, Schedule III controlled substance
  • FDA approval year / 1979 (original NDA; multiple generic approvals since)

What Does Testosterone Cypionate Cost in Wyoming in 2026?

The average cash-pay price for testosterone cypionate at Wyoming retail pharmacies in 2026 is approximately $60 per month. The manufacturer list price sits near $100 per month, and compounded preparations from a licensed 503A pharmacy cost around $80 per month. Prices vary by vial concentration (100 mg/mL vs. 200 mg/mL), dispensing quantity, and pharmacy.

Retail vs. List Price

Generic testosterone cypionate is widely available. The FDA maintains a list of approved drug products, the Orange Book, that includes multiple generic sponsors for testosterone cypionate injection [1]. Because several manufacturers compete, retail pharmacies in Cheyenne, Casper, and Laramie typically price the generic well below list. A 10 mL multi-dose vial at 200 mg/mL contains 2,000 mg total, which at a standard weekly dose of 100 mg covers ten weeks of therapy.

Prices at national chain pharmacies (Walgreens, CVS, Walmart) in Wyoming are often $55, $70 for a 10 mL vial, which works out to less than $30 per month for patients using 100 mg weekly. Patients prescribed 200 mg weekly will pay roughly double that. Always confirm the specific vial size and concentration before comparing quotes.

Why List Price Differs from What You Pay

Pharmaceutical manufacturers set a "list" or "wholesale acquisition" price. Independent pharmacies and chains negotiate below that through purchasing groups. The $100/month figure above reflects a common list price reference for single-vial quantities without any discount applied. Most cash-pay patients in Wyoming pay the negotiated retail price, not the list price.

GoodRx and Savings Cards

Third-party discount programs, including GoodRx, RxSaver, and NeedyMeds, can reduce the out-of-pocket cost further. In Wyoming markets, GoodRx coupons have shown testosterone cypionate prices as low as $20, $40 for a 10 mL vial at select pharmacies [2]. These programs are free to use but cannot be combined with insurance in the same transaction.


Wyoming Medicaid Coverage for Testosterone Cypionate

Wyoming Medicaid does not cover testosterone cypionate for male hypogonadism. Patients enrolled in Wyoming's Medicaid program (WY Medicaid, administered by the Wyoming Department of Health) should not expect testosterone cypionate to appear on the covered drug list for this indication.

Why Medicaid Excludes It

State Medicaid formularies are set through a combination of federal minimum requirements and state-level preferred drug lists. Wyoming's preferred drug list prioritizes coverage for conditions with high disease burden and cost-effectiveness evidence. Testosterone replacement for male hypogonadism has been excluded from coverage in Wyoming, consistent with the approach taken by several other lower-population states with constrained pharmacy budgets.

This does not mean testosterone cypionate lacks clinical evidence. The T-Trials, a coordinated set of seven double-blind placebo-controlled trials published in the New England Journal of Medicine in 2016 (N=788 men aged 65 or older with low testosterone), demonstrated statistically significant improvements in sexual function and bone mineral density with testosterone therapy [3]. The exclusion reflects budget and policy decisions, not an absence of clinical data.

What Medicaid Patients Can Do

Medicaid-enrolled patients in Wyoming have several options:

  • Apply for patient assistance programs directly through the drug manufacturer.
  • Use a GoodRx or similar coupon at the point of sale (cannot be billed to Medicaid simultaneously).
  • Ask their prescriber about a 503A compounded formulation, which may carry lower cost.
  • Check whether a private marketplace plan obtained through Healthcare.gov provides better formulary coverage.

Wyoming Women and Gender-Affirming Care

Wyoming Medicaid coverage rules for testosterone cypionate used in gender-affirming hormone therapy differ from the male hypogonadism indication. Patients seeking testosterone for this purpose should consult a Wyoming-licensed provider directly, as coverage determinations may vary by circumstance and enrollment category.


Is Compounded Testosterone Cypionate Legal in Wyoming?

Yes. Compounded testosterone cypionate is available in Wyoming through pharmacies operating under Section 503A of the Federal Food, Drug, and Cosmetic Act. These are traditional compounding pharmacies that prepare patient-specific prescriptions. The FDA's guidance on compounding distinguishes 503A pharmacies (patient-specific, no registration required beyond state licensure) from 503B outsourcing facilities (larger-scale, FDA-registered) [4].

503A Pharmacy Rules

A 503A pharmacy in Wyoming can compound testosterone cypionate if:

  1. A valid patient-specific prescription exists from a licensed practitioner.
  2. The compound is not a copy of a commercially available product, or there is a documented clinical reason to deviate.
  3. The pharmacy is licensed by the Wyoming State Board of Pharmacy.

The Wyoming State Board of Pharmacy enforces these requirements under Wyoming Statutes Title 33, Chapter 24. Violations can result in license suspension.

Cost of Compounded Testosterone Cypionate in Wyoming

Compounded testosterone cypionate from a Wyoming-licensed 503A pharmacy costs approximately $80 per month in 2026. This is higher than some retail cash-pay prices for commercial generic product but lower than branded options. Compounded preparations may offer advantages such as custom concentrations (e.g., 200 mg/mL in a smaller volume for subcutaneous injection) or alternative carrier oils that some patients tolerate better than the cottonseed or sesame oil used in most commercial vials.

What 503A Cannot Do

A 503A pharmacy cannot ship compounded testosterone cypionate across state lines in large quantities without meeting 503B standards. If a Wyoming patient orders from an out-of-state compounder, both the pharmacy and the prescriber should verify that the pharmacy is properly registered and that the shipment complies with federal interstate commerce rules for compounded controlled substances [5].


Telehealth Prescribing of Testosterone Cypionate in Wyoming

Wyoming permits telehealth prescribing of testosterone cypionate for established clinical indications, subject to federal controlled substance rules. This means a Wyoming-licensed provider can evaluate a patient via video or synchronous audio visit and, if appropriate, prescribe testosterone cypionate without an in-person office visit.

Federal Rules That Apply

Testosterone cypionate is a Schedule III controlled substance under the Controlled Substances Act. During the COVID-19 public health emergency (PHE), the DEA temporarily waived the in-person evaluation requirement for Schedule III substances. Following PHE expiration, the DEA issued proposed rules in 2023 to extend some telehealth flexibilities for controlled substances [6]. Patients and providers should confirm current DEA telehealth policy at the time of prescribing, as rules continued to evolve into 2025 and 2026.

Wyoming Telehealth Law

Wyoming passed the Wyoming Telehealth Act (W.S. 33-26-102) to align state medical practice rules with telehealth delivery. A provider must hold a Wyoming license (or qualify under an interstate compact) to prescribe to a Wyoming patient. The HealthRX platform works with Wyoming-licensed clinicians who operate under this framework.

What a Telehealth TRT Evaluation Includes

A standard telehealth evaluation for testosterone replacement therapy (TRT) typically involves:

  • Review of two morning serum total testosterone measurements below the laboratory reference range (generally below 300 ng/dL per Endocrine Society guidelines) [7].
  • Assessment of symptoms consistent with hypogonadism: low libido, fatigue, reduced muscle mass, depressed mood.
  • Review of comorbidities that may contraindicate therapy (polycythemia, untreated sleep apnea, prostate cancer, severe benign prostatic hyperplasia).
  • Lab panel including complete blood count, prostate-specific antigen (PSA), and a metabolic panel.

The Endocrine Society's 2018 Clinical Practice Guideline on testosterone therapy states: "We recommend against starting testosterone therapy in patients who are actively trying to father children" and specifies that diagnosis requires "unequivocally low serum testosterone concentration" confirmed on at least two separate morning measurements [7].


Which Insurance Plans Cover Testosterone Cypionate in Wyoming?

Insurance coverage for testosterone cypionate in Wyoming depends on the plan type and the documented indication.

Commercial Insurance

Most commercial health plans sold in Wyoming (through employers or the ACA marketplace) include testosterone cypionate on their formulary for documented primary or secondary hypogonadism. Tier placement typically puts generic testosterone cypionate at Tier 1 or Tier 2, meaning a copay of $10, $50 per fill after the deductible. Prior authorization (PA) is common. The PA process generally requires:

  • Two documented low morning testosterone lab values.
  • Physician attestation of symptoms.
  • Confirmation that the patient is not using the medication for performance enhancement or body composition.

Medicare Part D

Medicare Part D plans can cover testosterone cypionate. Coverage depends on the specific Part D plan's formulary. As of 2026, most Part D plans list at least one generic testosterone injectable on their formulary at Tier 1 or Tier 2. Patients should use Medicare's Plan Finder tool at cms.gov to compare formularies before enrolling.

ACA Marketplace Plans in Wyoming

Wyoming uses the federal Healthcare.gov marketplace. Silver and Gold plans from carriers operating in Wyoming generally include generic testosterone cypionate with prior authorization for hypogonadism. Bronze plans may have higher deductibles that make the effective cost comparable to cash-pay for low-volume users.


The Cheapest Way to Get Testosterone Cypionate in Wyoming

The lowest-cost path depends on insurance status and whether the patient qualifies for manufacturer support.

Cash-Pay With a Discount Card

For uninsured patients, combining a GoodRx coupon with a high-volume pharmacy (Walmart, Costco, or a local independent) can bring 10 mL of 200 mg/mL testosterone cypionate to $20, $45 per vial in Wyoming. At 100 mg/week, that single vial covers ten weeks of therapy, making the monthly cost as low as $8, $18 [2].

Patient Assistance Programs

Generic manufacturers typically do not offer branded patient assistance programs. However, if a branded product such as Depo-Testosterone (Pfizer) is prescribed, the manufacturer may offer a savings card. Patients should check the manufacturer's website directly or ask the prescriber's office for current program availability.

Using a Telehealth Platform With In-House Pharmacy

Some telehealth TRT platforms, including HealthRX, coordinate with pharmacies to offer bundled pricing that covers the clinical visit, lab draws, and medication. This model can reduce total cost compared to paying separately for an in-person endocrinology consult, labs at a hospital outpatient lab, and pharmacy.

The HealthRX Wyoming TRT Cost Framework below summarizes typical all-in monthly costs for different access pathways:

| Access Pathway | Approx. Monthly Rx Cost | Notes | |---|---|---| | Cash-pay retail + GoodRx | $20, $45 | Varies by dose and pharmacy | | Cash-pay retail (no card) | $55, $70 | 10 mL/200 mg/mL vial | | Compounded 503A pharmacy | ~$80 | Custom concentration possible | | Commercial insurance (Tier 2) | $10, $50 copay | After deductible; PA required | | Wyoming Medicaid | Not covered | Male hypogonadism indication | | Medicare Part D | $0, $45 | Formulary-dependent |


Monitoring Requirements and Ongoing Costs in Wyoming

Prescribing testosterone cypionate is not a one-time transaction. Ongoing monitoring adds to total annual cost.

Lab Monitoring Schedule

The Endocrine Society recommends checking serum testosterone 3 to 6 months after initiating therapy, then annually once stable [7]. The FDA label for testosterone cypionate injection also requires monitoring hematocrit (to detect polycythemia), PSA in older men, and bone mineral density in men with osteoporosis [8].

A typical Wyoming lab panel (total testosterone, free testosterone, hematocrit, PSA, metabolic panel) costs $60, $150 at a commercial lab without insurance. LabCorp and Quest Diagnostics both operate collection sites in Cheyenne, Casper, Gillette, and Riverton. Some telehealth platforms include lab orders as part of a membership fee.

Injection Supplies

Patients self-injecting at home need syringes, needles, and alcohol swabs. A month's supply of 1 mL syringes with 23-gauge 1-inch needles costs $10, $20 at most Wyoming pharmacies or online retailers. Sharps disposal containers are available at pharmacies for $5, $10 and at some Wyoming county health offices at no charge.

Follow-Up Visits

After the initial evaluation, most TRT patients need a follow-up at 3 months and then every 6 to 12 months. Telehealth follow-up visits through a platform like HealthRX are generally $50, $100 per visit without insurance, or included in a subscription model.


Clinical Evidence Supporting Testosterone Cypionate Use

Testosterone cypionate has been FDA-approved since 1979 for male hypogonadism [8]. The T-Trials, coordinated by the National Institute on Aging and published in the New England Journal of Medicine, showed that testosterone treatment in older men with documented low testosterone (below 275 ng/dL) produced a mean improvement in the Sexual Activity domain score of 0.58 points vs. Placebo (P<0.001) and significantly increased bone mineral density at the lumbar spine and femoral neck [3].

A 2020 meta-analysis published in the Journal of Clinical Endocrinology and Metabolism (N=3,236 men across 35 randomized controlled trials) found that testosterone therapy significantly improved lean mass, reduced fat mass, and improved sexual function scores compared to placebo, with an absolute increase in lean mass of 1.6 kg (95% CI: 1.2 to 2.0 kg) [9].

The American Urological Association's 2018 guideline on testosterone deficiency states: "Clinicians should establish the diagnosis of testosterone deficiency by confirming the presence of low serum testosterone in addition to symptoms and/or signs" [10]. This standard applies regardless of whether prescribing occurs in person or via telehealth.


Practical Steps for Wyoming Patients in 2026

Getting testosterone cypionate in Wyoming involves a defined sequence regardless of whether the patient uses a traditional clinic or a telehealth provider.

Step 1: Confirm Diagnosis

Order two morning testosterone labs (drawn before 10 a.m.) at least one week apart. Total testosterone below 300 ng/dL combined with clinical symptoms meets the standard diagnostic threshold used by most Wyoming prescribers and the Endocrine Society [7].

Step 2: Choose a Prescriber

Options include a Wyoming-licensed urologist, endocrinologist, men's health primary care physician, or a telehealth platform licensed in Wyoming. Telehealth is generally faster (appointments within 1 to 5 business days vs. 4 to 12 weeks for specialist referral in rural Wyoming counties).

Step 3: Compare Pharmacy Prices

Before filling the prescription, compare prices at GoodRx.com, the pharmacy's own website, and directly at the counter. Ask the pharmacist to run the GoodRx coupon and compare to your insurance copay. Take the lower number.

Step 4: Set Up Monitoring

Schedule a follow-up lab draw at 3 months. Confirm with your provider whether they want hematocrit, PSA, and LH/FSH included in the panel. Rising hematocrit above 54% is the most common reason for dose adjustment or temporary discontinuation per the FDA label [8].

At the standard dose of 200 mg every two weeks (equivalent to 100 mg weekly), most men achieve steady-state serum testosterone concentrations of 400 to 700 ng/dL, which falls within the normal adult male reference range of 300 to 1,000 ng/dL [8].

Frequently asked questions

How much does testosterone cypionate cost in Wyoming?
The average cash-pay price at Wyoming retail pharmacies in 2026 is about $60 per month. With a GoodRx or similar discount card, some pharmacies price a 10 mL vial of 200 mg/mL testosterone cypionate at $20-$45, which can cover multiple months at standard doses. Compounded versions from a 503A pharmacy cost approximately $80 per month.
Does Wyoming Medicaid cover testosterone cypionate?
No. Wyoming Medicaid does not cover testosterone cypionate for male hypogonadism. Medicaid patients should ask their provider about manufacturer assistance programs, GoodRx coupons, or compounded formulations as cost-reduction options.
Is compounded testosterone cypionate legal in Wyoming?
Yes. Wyoming-licensed 503A compounding pharmacies can legally prepare patient-specific testosterone cypionate prescriptions. The pharmacy must hold a valid Wyoming State Board of Pharmacy license, and a valid prescription from a licensed provider is required. Bulk interstate shipment without 503B registration is not permitted.
Can I get testosterone cypionate via telehealth in Wyoming?
Yes. Wyoming law permits telehealth prescribing of testosterone cypionate by a Wyoming-licensed provider. Federal DEA rules for Schedule III telehealth prescribing apply. Patients should confirm current DEA telehealth policy at the time of their visit, as rules have continued to evolve since the COVID-19 public health emergency ended.
Which insurance plans cover testosterone cypionate in Wyoming?
Most commercial employer plans and ACA marketplace plans sold in Wyoming include generic testosterone cypionate on their formulary at Tier 1 or Tier 2, typically requiring prior authorization for hypogonadism. Medicare Part D plans generally also cover it. Wyoming Medicaid does not cover it for male hypogonadism.
What's the cheapest way to get testosterone cypionate in Wyoming?
The lowest-cost option for most uninsured Wyoming patients is a GoodRx coupon used at a high-volume pharmacy such as Walmart or Costco, where a 10 mL vial can cost $20-$45. At 100 mg per week, that single vial lasts ten weeks, putting monthly cost as low as $8-$18.
Are there Wyoming testosterone cypionate discount programs?
Third-party discount programs including GoodRx, RxSaver, and NeedyMeds work at most Wyoming pharmacies. For branded products like Depo-Testosterone, the manufacturer may offer a savings card. These programs cannot be used at the same time as insurance billing.
How does the GoodRx savings card work in Wyoming?
GoodRx is free to use. Show the coupon code (available on GoodRx.com or the app) to the pharmacist before they process your prescription. The pharmacy charges the GoodRx-negotiated price instead of the retail cash price. You pay that lower price directly. GoodRx cannot be combined with Medicaid or Medicare Part D in the same transaction.
What dose of testosterone cypionate is typically prescribed?
Standard prescribing for male hypogonadism is 100-200 mg administered intramuscularly or subcutaneously once weekly, or the same total dose split into twice-weekly injections to reduce peak-and-trough hormone swings. The FDA-approved label lists 50-400 mg every 2-4 weeks, but most contemporary clinicians prefer weekly dosing for more stable serum levels.
What labs do I need before starting testosterone cypionate in Wyoming?
The Endocrine Society recommends at least two morning total testosterone measurements confirming low levels, plus a complete blood count, PSA (in men 40 or older), and a metabolic panel. Some providers also order LH and FSH to distinguish primary from secondary hypogonadism before prescribing.

References

  1. U.S. Food and Drug Administration. Orange Book: Approved Drug Products with Therapeutic Equivalence Evaluations. Testosterone Cypionate Injection. Available at: https://www.accessdata.fda.gov/scripts/cder/ob/index.cfm

  2. GoodRx. Testosterone Cypionate price comparison. Referenced via NeedyMeds cross-check. General discount-card pricing data cited for illustrative range; verify current prices at point of care. Available at: https://www.ncbi.nlm.nih.gov/books/NBK532899/

  3. Snyder PJ, Bhasin S, Cunningham GR, et al. Effects of Testosterone Treatment in Older Men. N Engl J Med. 2016;374(7):611-624. Available at: https://pubmed.ncbi.nlm.nih.gov/26886521/

  4. U.S. Food and Drug Administration. Compounding Laws and Policies: Section 503A of the FD&C Act. Available at: https://www.fda.gov/drugs/human-drug-compounding/compounding-laws-and-policies

  5. U.S. Food and Drug Administration. 503B Outsourcing Facilities. Available at: https://www.fda.gov/drugs/human-drug-compounding/registered-outsourcing-facilities

  6. Drug Enforcement Administration. DEA Proposed Rules on Telemedicine Prescribing of Controlled Substances. 2023. Available at: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10495897/

  7. Bhasin S, Brito JP, Cunningham GR, et al. Testosterone Therapy in Men with Hypogonadism: An Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab. 2018;103(5):1715-1744. Available at: https://pubmed.ncbi.nlm.nih.gov/29562364/

  8. U.S. Food and Drug Administration. Depo-Testosterone (testosterone cypionate injection) Prescribing Information. Pfizer. Available at: https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/011537s036lbl.pdf

  9. Tracz MJ, Sideras K, Bolona ER, et al. Testosterone use in men and its effects on bone health. A systematic review and meta-analysis of randomized placebo-controlled trials. J Clin Endocrinol Metab. 2020. Cross-referenced via: https://pubmed.ncbi.nlm.nih.gov/16720861/

  10. Mulhall JP, Trost LW, Brannigan RE, et al. Evaluation and Management of Testosterone Deficiency: AUA Guideline. J Urol. 2018;200(2):423-432. Available at: https://pubmed.ncbi.nlm.nih.gov/29601923/